Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis.

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis. Inflamm Bowel Dis. 2011 Jan; 17(1):22-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.